New study tracks how well alectinib keeps lung cancer from returning after surgery
NCT ID NCT06862869
First seen Jun 26, 2026 · Last updated Aug 07, 2026 · Updated 5 times
Summary
This study follows 800 Chinese patients with early-stage ALK-positive non-small-cell lung cancer who took alectinib after surgery to see how long they stay cancer-free. Researchers will collect real-world data on disease-free survival and patient characteristics. The goal is to understand how well alectinib works in everyday clinical practice.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Alectinib
- What this could lead to
- If successful, this study could confirm that alectinib helps prevent lung cancer from returning after surgery in ALK-positive patients, supporting its use in routine care.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be influenced by patient differences. It only includes Chinese patients, so findings may not apply globally.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
RECRUITINGGuangzhou, Guangzhou, 510095, China
-
Affiliated Hospital of Guangdong Medical University
RECRUITINGZhanjiang, Guangdong, 524001, China
-
Affiliated Hospital of Nantong University
RECRUITINGNantong, 226001, China
-
Affiliated Hospital of Zunyi Medical University
RECRUITINGZunyi, 563000, China
-
Anhui Provincial Hospital
RECRUITINGHefei, 230001, China
-
Cancer Hospital Chinese Academy of Medical Sciences Shenzhen Center
RECRUITINGShenzhen, 518127, China
-
Changzhou First People's Hospital
RECRUITINGChangzhou, 213003, China
-
Chest disease hospital of Tianjin City
RECRUITINGTianjin, China
-
Fujian Cancer Hospital
RECRUITINGFuzhou, 350014, China
-
General Hospital of Ningxia Medical University
RECRUITINGYinchuan, 750004, China
-
Harbin Medical University Cancer Hospital
RECRUITINGHarbin, 150081, China
-
Hebei Medical University Fourth Hospital
RECRUITINGShijiazhuang, 50011, China
-
Henan Provincial Chest Hospital
RECRUITINGZhengzhou, Henan, 450003, China
-
Huai He Hospital of Henan University
RECRUITINGKaifeng, Henan, 475001, China
-
Hunan Cancer Hospital
RECRUITINGChangsha, 410013, China
-
Huzhou Central Hospital
RECRUITINGHuzhou, 313000, China
-
Jiangmen Central Hospital
RECRUITINGJiangmen, 529030, China
-
Jiangsu Cancer Hospital
RECRUITINGNanjing, 210000, China
-
Jiangsu Province Hospital
RECRUITINGNanjing, 210008, China
-
Lanzhou University Second Hospital
RECRUITINGLanzhou, 730030, China
-
Liaoning Provincial Cancer Hospital
RECRUITINGShengyang, 110042, China
-
Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School
RECRUITINGNanjing, 210008, China
-
Ningbo No.2 Hospital
RECRUITINGNingbo, 315000, China
-
Peking University First Hospital
RECRUITINGBeijing, 100034, China
-
Shandong Provincial Hospital
RECRUITINGJinan, 250021, China
-
Shanghai Chest Hospital
RECRUITINGShanghai, 200030, China
-
Shanghai Pulmonary Hospital
RECRUITINGShanghai, 200433, China
-
Shanxi Provincial Cancer Hospital
RECRUITINGTaiyuan, 030013, China
-
Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital
RECRUITINGChengdu, 610072, China
-
Taizhou Hospital of Zhejiang Province
RECRUITINGTaizhou, 317000, China
-
The First Affiliated Hospital of Nanchang University
RECRUITINGNanchang, China
-
The First Affiliated Hospital of Xinjiang Medical University
RECRUITINGÜrümqi, Xinjiang, 830054, China
-
The First Affiliated Hospital, Chongqing Medical University
RECRUITINGChongqing, 400016, China
-
The Second Affiliated Hospital of Dalian Medical University
RECRUITINGDalian, 116027, China
-
The Second Affiliated Hospital of Xi'an Jiao Tong University
RECRUITINGXi'an, 710004, China
-
The Second Affiliated Hospital, Zhejiang University
RECRUITINGHangzhou, 310009, China
-
The Third Affiliated Hospital of Sun Yat-Sen University
RECRUITINGGuangzhou, 510630, China
-
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology
RECRUITINGWuhan, 430030, China
-
Wuhan Union Hospital Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, 430022, China
-
Wuxi People's Hospital
RECRUITINGWuxi, 214023, China
-
Xi'an International Medical Center Hospital
RECRUITINGXi'an, 710100, China
-
Xuanwu Hospital, Capital Medical University
ACTIVE_NOT_RECRUITINGBeijing, 100053, China
-
Zhejiang Cancer Hospital
RECRUITINGHangzhou, 310022, China
-
Zhongshan Hospital Fudan University
RECRUITINGShanghai, 200032, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immunotherapy be safely used in early lung cancer? a Real-World study investigates
- Can an oral chemo pill boost immunotherapy's power against lung cancer?
- Can an immunotherapy cocktail shrink inoperable lung tumors?
- Immunotherapy boosts radiation against early lung cancer
- Lab-Grown lung tumors could reveal why some drugs work and others fail
- AI-Powered navigation aims to pinpoint tiny lung nodules during surgery